Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment (PhGA) of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus

Maarit Tarkiainen,Erin Balay‐Dustrude,Alessandro Consolaro,Esi M. Morgan,Nicolino Ruperto,Veronika Rypdal,Maria Backström,Paula Vähäsalo,Beth S. Gottlieb,For the Paediatric Rheumatology International Trials Organisation, and the Pediatric Rheumatology Care & Outcomes Improvement Network and the PhGA consensus task force, For the Pediatric Rheumatology European Society (PRES) JIA working party

DOI: https://doi.org/10.1002/acr.25447

2024-10-12

Arthritis Care & Research

Abstract:Introduction The Physician global assessment (PhGA) is a tool used nearly ubiquitously by pediatric rheumatologists for assessment of patient disease activity status. However, this tool lacks standardization in its scoring. This survey aimed to identify score influencing factors, along with inclusion or exclusion of extra‐articular manifestations and imaging, when scoring the PhGA in juvenile idiopathic arthritis (JIA). Methods Electronic surveys were sent to PRINTO and PR‐COIN members who completed a previous survey on scoring of the PhGA. Respondents were asked to rank their top seven factors for inclusion in the PhGA for non‐systemic JIA (nsJIA) and systemic JIA (sJIA), along with ranking extra‐articular manifestations and imaging for inclusion. Frequency and percentage of rank, and Likert responses were analyzed, and geographic regions as well as level of experience were compared using Chi2 and Fisher's test. Results 276 respondents from 54 countries and 6 continents participated. For nsJIA, factors selected by >50% included number of swollen joints, active uveitis, duration of morning stiffness, and number of tender joints. For sJIA, factors selected by >50% were presence and duration of fever, laboratory tests, number of swollen joints, serositis, rash, hepatomegaly, lung disease, and lymphadenopathy. Agreement on inclusion of extra‐articular factors such as uveitis, macrophage activation syndrome, and sJIA associated lung disease had >70% moderate or strong agreement for inclusion, while psoriasis had only 50.5%, and imaging 64.7%. Variations in rank between different geographic regions or level of experience were minor. Conclusion This survey identifies factors which pediatric rheumatology providers find important for PhGA scoring of disease activity, documents varying agreement on inclusion of extra‐articular manifestations of disease and lays the framework for further consensus work.

rheumatology